Found: 6
Select item for more details and to access through your institution.
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-01404-3
- By:
- Publication type:
- Article
Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
- Published in:
- Journal of Molecular Medicine, 2013, v. 91, n. 3, p. 395, doi. 10.1007/s00109-012-0956-2
- By:
- Publication type:
- Article
The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 4, p. 840, doi. 10.1093/carcin/bgu018
- By:
- Publication type:
- Article
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-11045-8
- By:
- Publication type:
- Article
β-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2010, v. 88, n. 8, p. 796, doi. 10.1139/Y10-052
- By:
- Publication type:
- Article
Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2010, v. 88, n. 6, p. 676, doi. 10.1139/Y10-053
- By:
- Publication type:
- Article